Publications by authors named "Jan Mester"

Claim this Profile
A
Author Correction: Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation.
Samir Attoub, Kholoud Arafat, Nasseredine Kamel Hammadi, Jan Mester, Anne-Marie Gaben

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation.
Samir Attoub, Kholoud Arafat, Nasseredine Kamel Hammadi, Jan Mester, Anne-Marie Gaben

Sci Rep· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
Anne-Marie Gaben, Michèle Sabbah, Gérard Redeuilh, Monique Bedin, Jan Mester

BMC Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
Nadia Al Marzouqi, Rabah Iratni, Abderrahim Nemmar, Kholoud Arafat, Mahmood Ahmed Al Sultan, Jan Mester

Eur J Pharmacol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development.
Irène Netchine, Salah Azzi, Muriel Houang, Danielle Seurin, Laurence Perin, Jan Mester

J Clin Endocrinol Metab· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect participation of Hsp90 in the regulation of the cyclin E turnover.
Monique Bedin, Maria-Grazia Catelli, Lucien Cabanié, Anne-Marie Gaben, Jan Mester

Biochem Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Captopril as a potential inhibitor of lung tumor growth and metastasis.
Samir Attoub, Anne Marie Gaben, Suhail Al-Salam, M A H Al Sultan, Anne John, Jan Mester

Ann N Y Acad Sci· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
Asmaà Fritah, Cécile Saucier, Jan Mester, Gérard Redeuilh, Michèle Sabbah

Mol Cell Biol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
Anne-Marie Gaben, Cécile Saucier, Monique Bedin, Gérard Redeuilh, Jan Mester

Mol Endocrinol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest.
Monique Bedin, Anne-Marie Gaben, Cécile Saucier, Jan Mester

Int J Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts.
Anne-Marie Gaben, Cecile Saucier, Monique Bedin, Véronique Barbu, Jan Mester

Int J Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Samir Attoub, Christine Rivat, Sylvie Rodrigues, Saskia Van Bocxlaer, Monique Bedin, Jan Mester

Cancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases.
Gérard Redeuilh, Annette Attia, Jan Mester, Michèle Sabbah

Oncogene· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities.
Nathalie Villerbu, Anne-Marie Gaben, Gérard Redeuilh, Jan Mester

Int J Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis